PG
EVH icon

PEAK6 Group’s Evolent Health EVH Stock Holding History

PEAK6 Group’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$335K Sell
15,903
-5,787
-27% -$110K ﹤0.01% 2920
2018
Q1 		$309K Buy
+21,690
New +$310K ﹤0.01% 3018
2017
Q4 		– Sell
-17,032
Closed -$303K – 4279
2017
Q3 		$303K Sell
17,032
-28,727
-63% -$592K ﹤0.01% 2967
2017
Q2 		$1.16M Buy
45,759
+30,410
+198% +$731K 0.01% 1813
2017
Q1 		$342K Buy
+15,349
New +$295K ﹤0.01% 2597

Other funds holding EVH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

PEAK6 Group's EVH Position: Q2 2018 in Review

PEAK6 Group reduced its Evolent Health (EVH) stake by 27% in Q2 2018, selling an estimated $110K and leaving 15,903 shares worth $335K. The position accounts for ﹤0.01% of the portfolio, ranked #2920.

PEAK6 Group first reported a position in EVH in Q1 2017 and has held it in 5 quarters since. The position peaked at $1.16M in Q2 2017. 178 funds tracked by Wall St. Rank hold EVH as of Q2 2018.

  • PEAK6 Group held 15,903 shares of Evolent Health worth $335K as of Q2 2018.
  • PEAK6 Group sold 5,787 Evolent Health shares in Q2 2018, an estimated $110K.
  • Evolent Health made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #2920 holding.
  • PEAK6 Group first reported a position in Evolent Health in Q1 2017 and has held it in 5 quarters since.
  • PEAK6 Group's Evolent Health position peaked at $1.16M in Q2 2017.
  • 178 funds tracked by Wall St. Rank held Evolent Health as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.